SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-049802
Filing Date
2020-09-09
Accepted
2020-09-09 08:49:14
Documents
2
Period of Report
2020-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1563
2 EX-24 DOCUMENT attachment1.htm EX-24 4273
  Complete submission text file 0001209191-20-049802.txt   7289
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Eckhardt Sue Gail (Reporting) CIK: 0001823769 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37813 | Film No.: 201165601